EPA Issues Emergency Order to Stop Use of Pesticide Dacthal to Address Serious Health Risk

WASHINGTON – Today, Aug. 6, the U.S. Environmental Protection Agency is announcing the emergency suspension of all registrations of the pesticide dimethyl tetrachloroterephthalate (DCPA or Dacthal) under the Federal Insecticide, Fungicide and Rodenticide Act (FIFRA). This is the first time in almost 40 years EPA has taken this type of emergency action, following several years of unprecedented efforts by the Biden-Harris Administration to require the submission of long-overdue data and then assess and address the risk this pesticide poses.

“DCPA is so dangerous that it needs to be removed from the market immediately.”

—Michal Freedhoff
Assistant Administrator for the Office of Chemical Safety and Pollution Prevention

EPA has taken this action because unborn babies whose pregnant mothers are exposed to DCPA, sometimes without even knowing the exposure has occurred, could experience changes to fetal thyroid hormone levels, and these changes are generally linked to low birth weight, impaired brain development, decreased IQ, and impaired motor skills later in life, some of which may be irreversible.

“DCPA is so dangerous that it needs to be removed from the market immediately,” said Assistant Administrator for the Office of Chemical Safety and Pollution Prevention Michal Freedhoff. “It’s EPA’s job to protect people from exposure to dangerous chemicals. In this case, pregnant women who may never even know they were exposed could give birth to babies that experience irreversible lifelong health problems. That’s why for the first time in almost 40 years, EPA is using its emergency suspension authority to stop the use of a pesticide.”

“Alianza is pleased to see the EPA make this historic decision.  As an organization led by farmworker women, we know intimately the harm that pesticides, including dimethyl tetrachloroterephthalate (DCPA or Dacthal), can inflict on our bodies and communities.  This emergency decision is a great first step that we hope will be in a series of others that are based on listening to farmworkers, protecting our reproductive health, and safeguarding our families.”.

—Mily Treviño Sauceda
Executive Director of Alianza Nacional de Campesinas

“Farmworkers face burdensome conditions in the fields and often face exposure to harmful pesticides while working to feed our nation. I applaud the emergency action by the EPA which prioritizes farmworker health and safety, especially for pregnant women, by suspending this harmful chemical from our agricultural systems. We must continue to build on this progress and ensure all farmworkers are given the protection, worker’s rights, and overtime pay they deserve,” said Congressman Raúl Grijalva (AZ-07).

“Alianza is pleased to see the EPA make this historic decision.  As an organization led by farmworker women, we know intimately the harm that pesticides, including dimethyl tetrachloroterephthalate (DCPA or Dacthal), can inflict on our bodies and communities.  This emergency decision is a great first step that we hope will be in a series of others that are based on listening to farmworkers, protecting our reproductive health, and safeguarding our families,” said Mily Treviño Sauceda, Executive Director of Alianza Nacional de Campesinas.

Background on DCPA and Biden-Harris Administration Efforts to Assess and Address Risks

DCPA is a pesticide registered to control weeds in both agricultural and non-agricultural settings, but is primarily used on crops such as broccoli, Brussels sprouts, cabbage and onions. DCPA is currently undergoing registration review, a process that requires reevaluating registered pesticides every 15 years to ensure they cause no unreasonable adverse effects on human health or the environment.

In deciding whether to issue today’s Emergency Order, EPA consulted with the U.S. Department of Agriculture to understand how growers use DCPA and alternatives to this pesticide. In 2013, the agency issued a Data Call-In (DCI) to AMVAC Chemical Corporation, the sole manufacturer of DCPA, requiring it to submit more than 20 studies to support the existing registrations of DCPA. The required data included a comprehensive study of the effects of DCPA on thyroid development and function in adults and in developing young before and after birth, that was due by January 2016. Several of the studies that AMVAC submitted from 2013-2021 were considered insufficient to address the DCI, while the thyroid study and other studies were not submitted at all.

In April 2022, EPA issued a very rarely used Notice of Intent to Suspend the DCPA technical-grade product (used to manufacture end-use products) based on AMVAC’s failure to submit the complete set of required data for almost 10 years, including the […]

Full article: www.epa.gov